Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
1.300
-0.070 (-5.11%)
At close: Feb 21, 2025, 4:00 PM
1.379
+0.079 (6.10%)
After-hours: Feb 21, 2025, 7:58 PM EST
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $5.76 million as of February 21, 2025. Its market cap has decreased by -69.80% in one year.
Market Cap
5.76M
Enterprise Value
5.12M
1-Year Change
-69.80%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $5.76M, a decrease of -98.22%. That is a compound annual growth rate of -71.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 6.07M | -35.07% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |